Without compounded versions to shore up supply, we worry that patients are going to have access issues with this medication. That could push patients from the sometimes-complicated world of compounded drugs into far-less-certain territory
Patients should share any medical concerns, such as diabetes, digestive issues, or past medication side effects
HGH is known for promoting fat breakdown
In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more
So Michelle Oravitz: That's really interesting